Home > About > History


The US Department of Energy (DOE) selects GLE for future operations at its Paducah, Kentucky Site. The DOE and GLE continue negotiations for a 40-year contract to have the SILEX Technology commercially deployed for the re-enrichment of depleted uranium tails.

Solar Systems completes the first off-shore deployment of its unique ‘Dense Array’ dish concentrator solar technology, a 1MW solar power plant at the Nofa Equestrian Resort, near Riyadh, Kingdom of Saudi Arabia.

In June, Silex announces completion of a strategic review of the entire business, determining to refocus efforts on its primary economic asset, the SILEX laser-based uranium enrichment technology. The strategic review also involves an accelerated transition to market for Solar Systems and Translucent and results in the cessation of operations at ChronoLogic.

In July, GLE announces its own restructure in response to worsening trading conditions in the global nuclear fuel markets, initially triggered by the events in Fukushima, Japan in March 2011. The changes result in the consolidation of GLE’s operations. Importantly, the key commercial terms of Silex’s license agreement with GLE do not change.

In May, GLE and Silex achieve the successful completion of the Test Loop Program Phase I Milestone: Technology Demonstration and Validation in Wilmington, North Carolina – triggering a US$15 million milestone payment from GLE to Silex (which is received in July).

In June, Solar Systems complete construction of Australia’s largest CPV Solar Plant – a 1.5MW Solar Demonstration Facility at Mildura, Victoria.

Silex lists on the OTCQX exchange in the US under the symbol ‘SILXY’ in June.

Solar Systems is awarded a funding grant from the Australian Solar Institute. The business also secures a site for a facility at the Nofa Equestrian Resort near Riyadh, Saudi Arabia with construction of a 1MW facility commencing during the year. Solar Systems open its 0.6MW Test and Demonstration Facility at Bridgewater, Victoria.

In September, the US NRC approves the world’s first Construction and Operating License for a commercial laser enrichment plant utilising the SILEX Technology at Wilmington, North Carolina.

Silex successfully completes an $89 million capital raising and a share purchase plan which raises a further $20 million.
In March, Silex acquires the business assets of Melbourne-based Solar Systems Group. Solar Systems’ concentrating photovoltaic (CPV) technology is applicable to large utility-scale solar power generation, using its unique ultra-high efficiency ‘Dense Array’ dish technology.

In April, GLE and Silex announce the successful completion of the Test Loop initial measurement program.

In August, the US NRC announces it has accepted GLE’s license application to construct and operate a commercial SILEX uranium enrichment facility in Wilmington, triggering a ~30 month review process.

In July, GLE announces the on-schedule start-up of the Test Loop to evaluate the next-generation SILEX laser-based uranium enrichment technology.

Global Laser Enrichment (GLE), formed as a subsidiary of GE-Hitachi Nuclear Energy (GEH) to commercialise the SILEX Technology, announces it has selected its Wilmington, North Carolina,headquarters site for the first potential commercial SILEX uranium enrichment facility.

GLE is notified that the US Nuclear Regulatory Commission (NRC) has approved a license to operate the Test Loop for the demonstration of the next generation SILEX laser enrichment technology.

GEH and Cameco Corp. announce that Cameco Corporation, the world’s largest uranium producer, has joined the GLE venture. Cameco paid US$123.8 million for a 24% stake in GLE. GE retains 51% ownership with Hitachi at 25%.

Transfer of the SILEX Uranium Enrichment Project to GE’s Wilmington, North Carolina (USA) nuclear fuel plant is completed in the first half. Hitachi joins GE as project partner.

GE-Hitachi signs Letters of Intent for uranium enrichment services and support using the SILEX Technology with Exelon and Entergy – the two largest nuclear power utilities in the US.

Silex successfully completes a $50 million capital raising in October.

Silex and the General Electric Company sign an exclusive Technology Commercialisation and License Agreement for the SILEX Uranium Enrichment Technology in May, with US Government authorisations received in October.

Silex increases its stake in ChronoLogic to 90%.

Translucent wins a US Defence Department DARPA Grant to help develop the ‘optical silicon’ technology, under DARPA’s Electronics and Photonics Integrated Circuits (EPIC) Program.

ChronoLogic wins a Federal Government Commercial Ready Grant for its novel ‘USB- inSync™’ Data Acquisition technology.

Silex successfully commissions the world’s first silicon laser enrichment pilot plant.

Translucent secures its first US Patent for ‘optical silicon’ and filed patents for Silicon-on- Insulator (SOI) and dielectric substrates for the semiconductor industry.

Silex takes a majority ownership in Translucent Inc., moving to ~70% interest (from 30%).
Silex acquires a controlling 51% interest in ChronoLogic Pty Ltd, an Adelaide-based start-up developing novel technology for the electronics and instrumentation industries.

The SILEX Uranium Enrichment Project achieves a key milestone with the first full demonstration on practical uranium enrichment using the SILEX ‘Direct Measurement Facility’ at Lucas Heights, Sydney.

Silex enters the semiconductor materials field with the founding investment for Translucent Inc., a Silicon Valley start-up developing silicon photonics technology.

The SILEX Technology is officially Classified by the US and Australian Governments. The implications of classification relate mainly to security protocols.

An Agreement for Cooperation between the US and Australian Governments is signed, paving the way for continued development of the SILEX Technology for uranium enrichment, and facilitating its future transfer to the US.

The first macroscopic demonstration of the SILEX uranium process is successfully achieved.

Silex wins the 2000 Australian Technology Award for Excellence in the Manufacturing and Engineering sector.

Silex raises $36 million through a share issue to assist in funding the development of its technology portfolio.

Silex lists on the Australian Stock Exchange (ASX) under the symbol ‘SLX’.
Silex is divested from Sonic Healthcare Limited and sets about establishing the commercial viability of the SILEX Technology.
‘Proof of Principle’ demonstration of the SILEX Process is achieved at the Company’s laboratories in Lucas Heights, Sydney. Uranium enrichment, the largest market for isotope separation, becomes Silex’s primary focus.
The unique principles of the SILEX (Separation of Isotopes by Laser EXcitation) Process are formulated.
Silex begins researching the isotope separation concepts of co-inventors Dr Michael Goldsworthy and Dr Horst Struve.
Silex is established by founder Dr Michael Goldsworthy as a technology research and development subsidiary of Sonic Healthcare Limited, an Australian publicly listed company.